Although more sensitive techniques including the ligase detection assay and high amplicon melting PCR have been used to identify the BRAF mutation in other tissues including cutaneous melanoma they have not been applied to uveal melanoma (Turner et al, 2005; Willmore-Payne et al, 2005). The gene discussed is BRAF; the disease is cutaneous melanoma.